OTCMKTS:AVCNF Avicanna (AVCNF) Stock Price, News & Analysis $0.07 +0.00 (+2.46%) As of 10/15/2026 11:03 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Avicanna Stock (OTCMKTS:AVCNF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avicanna alerts:Sign Up Key Stats Today's Range$0.07▼$0.0750-Day Range$0.07▼$0.1052-Week Range$0.06▼$0.21Volume100 shsAverage Volume74,517 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Avicanna Inc. is a Canadian biopharmaceutical company focused on the development, production and commercialization of cannabinoid-based products. The company combines research and development with agricultural and manufacturing capabilities to create pharmaceutical, medical and consumer products derived from cannabis compounds, including cannabidiol (CBD) and other cannabinoids. Avicanna’s activities include cannabinoid formulation, clinical research and product development in areas such as medical cannabis, dermatology and other therapeutic applications. Its product portfolio has included medical cannabis products marketed under the RHO Phyto brand in Canada, as well as cannabinoid-based formulations intended for use in pharmaceutical and wellness markets. The company has operated internationally, with a significant presence in Colombia, where it has conducted cannabis cultivation, processing and research activities, while also serving markets in Canada and other jurisdictions subject to applicable regulatory approvals. Avicanna was founded in 2016 and is led by Chief Executive Officer Aras Azadian.AI Generated. May Contain Errors. Read More Receive AVCNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avicanna and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVCNF Stock News HeadlinesAvicanna Inc. (OTCMKTS:AVCNF) Sees Significant Drop in Short InterestOctober 13 at 1:43 AM | americanbankingnews.comAvicanna to Present at a Life Sciences Investor Forum on September 17, 2026September 15, 2026 | globenewswire.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery. | Behind the Markets (Ad)Avicanna Launches MyMedi.ca Integrated Healthcare Program in CanadaSeptember 9, 2026 | globenewswire.comAvicanna Inc.August 26, 2026 | marketwatch.comAvicanna Secures Strategic Private Placement Led by Pharma Investor Michael PorterAugust 19, 2026 | tipranks.comAvicanna Announces Closing of Strategic Non-Brokered Private PlacementAugust 19, 2026 | financialpost.comFAvicanna Announces Closing of Strategic Non-Brokered Private PlacementAugust 19, 2026 | globenewswire.comSee More Headlines AVCNF Stock Analysis - Frequently Asked Questions How have AVCNF shares performed this year? Avicanna's stock was trading at $0.1621 at the start of the year. Since then, AVCNF shares have decreased by 53.8% and is now trading at $0.0749. How do I buy shares of Avicanna? Shares of AVCNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:AVCNF Previous SymbolOTC:AVCNF CIKN/A Webwww.avicanna.com Phone1.647.243.5283FaxN/AEmployees87Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:AVCNF) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersI have publicly predicted six major American crashes, before each one happened.Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA simple options strategy that changed one trader's pathIan Cooper went from a financially stressed, struggling journalist to a trader who discovered a repeatable opt...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avicanna Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avicanna With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
